SEGN Seegnal Inc.
Seegnal Inc. provides SaaS clinical division support solutions. Its clinical decision support platform designed to empower clinicians in managing and resolving patient-specific drug-related problems. Its platform integrates with electronic medical records or other relevant systems that gather an array of applicable data into a patented interface, as well as clinicians gain instant access to vital information, enabling to make informed decisions at the point of care. The company is based in Calgary, Canada.…
Industry Peers
Health Information ServicesKey Statistics
About Seegnal (CVE: SEGN)
›
Seegnal (CVE: SEGN) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Health Information Services industry, part of the Healthcare sector.
The shares were at 0.1000 CAD on 18 November 2026, down 66.7% over 52 weeks. Its 52-week range is 0.1000 CAD to 0.3700 CAD, and it trades at the bottom of that range.
Its market capitalisation is 4.68M CAD.
Seegnal reports return on equity of 110.7%, an operating margin of -245.5% and revenue up 14.7% year over year.
Its debt exceeds its cash by 2.50M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. The next earnings report is expected on 26 November 2026.